Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
暂无分享,去创建一个
Nahum Sonenberg | N. Sonenberg | I. G. Fantus | R. Dowling | M. Pollak | Michael Pollak | M. Zakikhani | Mahvash Zakikhani | Ryan Dowling | I George Fantus
[1] L. Donehower,et al. Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. , 2004, The Journal of nutrition.
[2] P. Richardson,et al. Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial. , 2006, Journal of Clinical Oncology.
[3] B. Kemp,et al. Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.
[4] Dario R Alessi,et al. Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.
[5] Lewis C Cantley,et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Yee,et al. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer. , 2006, Cancer research.
[7] S. Hankinson,et al. Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.
[8] K. Jishage,et al. Role of Lkb1, the causative gene of Peutz–Jegher's syndrome, in embryogenesis and polyposis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Belfiore,et al. Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved* , 2002, The Journal of Biological Chemistry.
[10] M. Stratton,et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.
[11] B. Hoffman,et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Hardie,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[13] W. Holland,et al. Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. , 2004, Biochemical pharmacology.
[14] Margaret S. Wu,et al. Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.
[15] S. Majumdar,et al. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin , 2006, Diabetes Care.
[16] R. DePinho,et al. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.
[17] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[18] D. Kritchevsky,et al. Influence of caloric intake on experimental carcinogenesis: a review. , 1986, Advances in experimental medicine and biology.
[19] L. Witters. The blooming of the French lilac. , 2001, The Journal of clinical investigation.
[20] S. Goodman,et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.